CN103566282A - Traditional Chinese medicine composition with anti-tumor effect and preparation method thereof - Google Patents
Traditional Chinese medicine composition with anti-tumor effect and preparation method thereof Download PDFInfo
- Publication number
- CN103566282A CN103566282A CN201210265111.6A CN201210265111A CN103566282A CN 103566282 A CN103566282 A CN 103566282A CN 201210265111 A CN201210265111 A CN 201210265111A CN 103566282 A CN103566282 A CN 103566282A
- Authority
- CN
- China
- Prior art keywords
- parts
- bran
- powder
- stir
- processed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Abstract
The invention relates to a traditional Chinese medicine composition with an anti-tumor effect. The composition is prepared through the following steps: preparing following medicinal materials in parts by weight: 1 to 5 parts of curcuma tuber, 1 to 5 parts of hairyvein agrimony, 1 to 5 parts of flying squirrel feces, 1 to 5 parts of alum, 1 to 5 parts of nitre, 0.5 to 3 parts of prepared dry paint, 3 to 7 parts of bitter orange stir-fried with bran, and 0.5 to 4 parts of semen strychni powder; grinding curcuma tuber, bitter orange stir-fried with bran, and prepared dry paint, which are selected from the 8 medicinal materials mentioned above, then extracting the powder with ethanol, subjecting the extracting solution to a reduced pressure treatment so as to obtain an extract A, preserving the dregs for later use; adding hairyvein agrimony, alum, nitre, flying squirrel feces, and the dregs into water; decocting the water, filtering the decocted liquid, condensing and drying the filtrate so as to obtain powder B; and finally evenly mixing the extract A, the powder B, and semen strychni powder so as to obtain the composition. The effect of the composition is stronger than that of a composition prepared by a conventional technology, besides the composition has the advantages of low usage amount, and good compliance of patients.
Description
Technical field
The present invention relates to field of medicaments, be particularly related to Chinese medicine composition of a kind of antitumor action and preparation method thereof.
Background technology
The flat oral preparation for eliminating of existing Chinese patent medicine comprises tablet, capsule, is a kind of conventional antineoplastic Chinese traditional medicine.One the 639th page of < < Chinese Pharmacopoeia > > version in 2010, record prescription, method for making, character and discriminating etc.Concrete method for making is: above eight taste medical materials, and Resina Toxicodendri, Oletum Trogopterori, Alumen, Sal Nitri are ground into fine powder; Radix Curcumae, stir-baked Fructus Aurantii in bran are ground into coarse powder, with 70% ethanol, are solvent, carry out percolation, collect percolate 600ml, reclaim ethanol, standby; Medicinal residues and Herba Agrimoniae decoct with water secondary, filter, and merging filtrate also merges with above-mentioned percolate, and concentrating under reduced pressure becomes thick paste, dry, adds Semen Strychni Pulveratum, above-mentioned fine powder and starch appropriate, mixes, and granulates, dry, incapsulates, makes 1000, obtains capsule.Or add Semen Strychni Pulveratum, above-mentioned fine powder and right amount of auxiliary materials, mix, granulate, dry, be pressed into 1000, sugar coating or film-coat, obtain tablet.
In the prior art, the oral dose of PINGXIAO JIA0NANG and PINGXIAO PIAN is 4-8 tablet/time or 4-8 piece/times, and the drug loading of preparation is lower, and patient's compliance is more weak, thereby affects the treatment.
Summary of the invention
In order to solve the problems of the technologies described above, the invention provides a kind of stable curative effect, the Chinese medicine composition that drug loading is high and preparation method.
A further object of the invention is to provide the pharmaceutically acceptable preparation that contains said composition.
The present invention is achieved by the following technical solutions.
The Chinese medicine composition of a kind of antitumor action of the present invention, by following step, prepared:
(1) get weight portion medical material Radix Curcumae 1-5 part, Herba Agrimoniae 1-5 part, Oletum Trogopterori 1-5 part, Alumen 1-5 part, Sal Nitri 1-5 part, Resina Toxicodendri 0.5-3 part processed, stir-baked Fructus Aurantii in bran 3-7 part, Semen Strychni Pulveratum 0.5-4 part;
(2) above 8 taste medical materials, get Radix Curcumae, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed and pulverize, ethanol extraction, and the extracting solution extractum A that reduces pressure to obtain, medicinal residues are standby;
(3) get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues and decoct with water, decoction liquor is filtered, and filtrate concentrate drying obtains powder B;
(4) above-mentioned extractum A, powder B and Semen Strychni Pulveratum mix.
Preferably, described in above-mentioned steps (1), get weight portion medical material Radix Curcumae 2-4 part, Herba Agrimoniae 2-4 part, Oletum Trogopterori 2-4 part, Alumen 2-4 part, Sal Nitri 2-4 part, Resina Toxicodendri 0.5-2 part processed, stir-baked Fructus Aurantii in bran 4-6 part, Semen Strychni Pulveratum 1-3 part.Optimally, described in step (1), get 3 parts of weight portion medical material Radix Curcumaes, 3 parts of Herba Agrimoniaes, 2.5 parts of Oletum Trogopteroris, 3 parts of Alumens, 3 parts, Sal Nitri, 1 part of Resina Toxicodendri processed, 5 parts of stir-baked Fructus Aurantii in bran, 2 parts of Semen Strychni Pulveratums.
Radix Curcumae described in above-mentioned steps (2), stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed are pulverized ethanol extraction method, include but not limited to: reflux, extract,, supersound extraction, carbon dioxide supercritical fluid extraction, microwave extraction, percolation etc., preferably percolation.Be specially described Radix Curcumae, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed pulverizing 60-80% ethanol percolation, collect percolate, decompression recycling ethanol obtains extractum A.The best is described Radix Curcumae, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed pulverizing 70% ethanol percolation, collects percolate, and decompression recycling ethanol obtains extractum A.
Percolation of the present invention is according to the percolation operation under pharmacopeia fluid extract and extractum item.
Preferably, get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues described in above-mentioned steps (3) decoct with water 1-3 time, each 1-3 hour, and decoction liquor is filtered and is merged, and filtrate concentrate drying obtains powder B.
Optimally, get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues described in step (3) decoct with water 2 times, and each 2 hours, decoction liquor was filtered and merged, and filters, and filtrate concentrate drying obtains powder B.
The preparation method of antitumor action Chinese medicine composition of the present invention, comprises the steps:
(1) get weight portion medical material Radix Curcumae 1-5 part, Herba Agrimoniae 1-5 part, Oletum Trogopterori 1-5 part, Alumen 1-5 part, Sal Nitri 1-5 part, Resina Toxicodendri 0.5-3 part processed, stir-baked Fructus Aurantii in bran 3-7 part, Semen Strychni Pulveratum 0.5-4 part;
(2) above 8 taste medical materials, get Radix Curcumae, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed and pulverize, ethanol extraction, and the extracting solution extractum A that reduces pressure to obtain, medicinal residues are standby;
(3) get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues and decoct with water, decoction liquor is filtered, and filtrate concentrate drying obtains powder B;
(4) above-mentioned extractum A, powder B and Semen Strychni Pulveratum mix.
Preferably, preparation method of the present invention, comprises the steps:
(1) get weight portion medical material Radix Curcumae 2-4 part, Herba Agrimoniae 2-4 part, Oletum Trogopterori 2-4 part, Alumen 2-4 part, Sal Nitri 2-4 part, Resina Toxicodendri 0.5-2 part processed, stir-baked Fructus Aurantii in bran 4-6 part, Semen Strychni Pulveratum 1-3 part;
(2) above 8 taste medicine Radix Curcumaes, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed are pulverized and are used 60-80% ethanol percolation, collect percolate, and decompression recycling ethanol obtains extractum A;
(3) get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues and decoct with water 1-3 time, each 1-3 hour, decoction liquor is filtered and is merged, and filters, and filtrate concentrate drying obtains powder B;
(4) above-mentioned extractum A, powder B and Semen Strychni Pulveratum mix.
Best, preparation method of the present invention, comprises the steps:
(1) get 3 parts of weight portion medical material Radix Curcumaes, 3 parts of Herba Agrimoniaes, 2.5 parts of Oletum Trogopteroris, 3 parts of Alumens, 3 parts, Sal Nitri, 1 part of Resina Toxicodendri processed, 5 parts of stir-baked Fructus Aurantii in bran, 2 parts of Semen Strychni Pulveratums;
(2) get Radix Curcumae, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed pulverizing 70% ethanol percolation, collect percolate, decompression recycling ethanol obtains extractum A;
(3) get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues and decoct with water 2 times, each 2 hours, decoction liquor was filtered and is merged, and filters, and filtrate concentrate drying obtains powder B;
(4) above-mentioned extractum A, powder B and Semen Strychni Pulveratum mix.
Preparation method of the present invention, wherein step and parameter be all inventor on the basis of existing technology, in the situation that keeping original drug effect constant, for the extraction process of the creative screening of active function of each medical material.
Radix Curcumae: be the tuber of zingiberaceous plant Rhizoma Curcumae Longae, Radix Curcumae or Rhizoma Curcumae.According to data: contained elemene energy direct killing cancerous cell in Radix Curcumae, can induce HL
60apoptosis (IC
50=27.5 μ g/mL), curcumin is under 300mg/kg dosage, to mice S
180sarcoma, mice Emhorn solid tumor have obvious inhibitory action; In test, curcumin is to HL in vitro
60cell, K
562cell, SGC
7901cell, Bel
7402cell all has obvious inhibitory action, its IC
50scope is 0.56～4.15 μ g/mL.Curcumin has many-sided pharmacological action, as effects such as antiinflammatory, antioxidation, blood fat reducing and atherosclerosis, antitumor, especially as a kind of cancer therapy drug with good development prospect, day by day causes people's attention, becomes the focus of research.In recent years, the experimentation of curcumin antitumaous effect is shown, curcumin can suppress the growth of the inside and outside tumor cell of body, and its anticancer spectrum is wider, and toxic and side effects is little, is a kind of PTS with wide application prospect.It can effectively suppress the vascular smooth muscle cell proliferation of the EGF-R ELISA stimulation of part induction, show that curcumin has much DEVELOPMENT PROSPECT at anti-proliferative disease as aspects such as tumors, curcumin is to Chemical Carcinogenesis such as benzopyrene, nitrosamine, nitrosoguanidine, TPA with the sudden change of cancer base is carcinogenic has a good protective action simultaneously.Someone has inquired into curcumin antioxidative characteristic from the angle of curcumin structure activity relationship, finds that curcumin contains Liang Ge p-OH group, and this group has anti-oxidation characteristics, for antimutagenic activity, is also essential.Therefore the antimutagenic of curcumin and the non-oxidizability of p-OH may have close relationship, and curcumin oxidation resistance is parallel with its antitumous effect.
Herba Agrimoniae: Herba Agrimoniae is named again Radix Agrimoniae is rosaceous a kind of herbaceos perennial.Its anticancer main component is agrimonine, is a kind of tannic acid, is a kind of potential antitumorigenic substance, can act on tumor cell and strengthen the immunoreation of animal body with some immunocytes.External inhibition test shows, Herba Agrimoniae water solubility extract all has inhibitory action to the infiltration of several tumor cells, and increasing and strengthen with concentration.By intraperitoneal administration, can suppress MM completely
2the growth of cell, and suppress MH
134the growth of hepatocarcinoma and Meth-A fibrosarcoma.No matter Herba Agrimoniae is the tumor cell to In vitro culture, or laboratory animal transplanted tumor all has inhibition or lethal effect, and can also improve tumor mice immunologic function and life cycle.Agrimophol also has stronger antitumor action.Find after deliberation, agrimophol has certain killing action to cancerous cell, in vitro tests shows: agrimophol just has certain killing action to same volume hepatic ascites oncocyte when 0.16mg/mL concentration, and can in 1h, this cancerous cell of same volume all be killed when 1.25mg/mL concentration; Can obviously extend the lotus tumor ehrlich ascites carcinoma mouse survival time, 24 of hepatic ascites cancer mices, lumbar injection agrimophol energy significant prolongation mouse survival time, increase in life span 49.6%; Agrimophol injection is to the good therapeutical effect of animal solid tumor tool, to S
37and U
14growth inhibition ratio be respectively 47.0% and 38.7 ‰ couples of S
180the suppression ratio of regulating liver-QI carcinosarcoma is respectively 26.3% and 23.5%.
Fructus Aurantii: be the dry immature fruit of rutaceae Citrus aurantium Linn. Citrus aurantium L. and variety thereof.Main active is Nobiletin, the ED to nasopharyngeal carcinoma KB cell
50be 3～28 μ g/mL.Also effective to Mice Bearing Lewis Lung Cancer and Wa Ke carcinoma 256 in body.
Resina Toxicodendri: be the resin of Anacardiaceae plant Toxicodendron verniciflnum (Stokes) F. A. Barkley (Rhus verniciflua Stokes) Toxicodendron vernicifluum (Stokes) the F.A.Barkl. dry product after processing.
4 kinds of triterpene tool cytotoxic effects that contain in Oletum Trogopterori, toxic action successful to the P388 type granulocyte leukemia of cell culture, can obviously reduce prostaglandin E (PGE) content of inflammation tissue, but serum glucocorticoids level is not made significant difference, show that its antiinflammatory action may and discharge relevant with the synthetic of inhibition PGE.
Alumen, Sal Nitri: the classic prescriptions of boiling according to Alumen and Sal Nitri decocting, as Alumen soup, Radix Et Rhizoma Rhei Sal Nitri soup etc.
Semen Strychni: another name vomiting nut, effective ingredient is Strychnos alkaloid.
The present invention also provides the Chinese medicine composition with antitumor action to make pharmaceutically acceptable preparation.Said composition shared percentage by weight in preparation can be 0.1～99.9%, and all the other are medicine acceptable carrier, according to preparation conventional method, prepares.
Compositions of the present invention, its pharmaceutical dosage forms can be any oral formulations or injection.Wherein oral formulations includes but not limited to: conventional tablet, sugar coated tablet, film coated tablet, enteric coated tablet; Capsule, hard capsule, soft capsule, oral liquid, buccal tablet, oral cavity disintegration tablet, granule, electuary, pill, powder, unguentum, sublimed preparation, suspensoid, powder, drop pill, pellet, suppository, cream, spray etc.; Injection includes but not limited to: intravenous injection, injectable powder, subcutaneous injection agent etc.The preferred capsule of the present invention.Oral consumption 3-5 tablet/time, every day 3 times.
Compositions of the present invention, when being prepared into medicament, optionally add applicable medicine acceptable carrier, described medicine acceptable carrier is selected from: mannitol, sorbitol, sodium pyrosulfite, sodium sulfite, sodium thiosulfate, cysteine hydrochloride, TGA, methionine, vitamin C, EDETATE SODIUM, Ethylenediaminetetraacetic Acid Calcium Salt, the alkali-metal carbonate of monovalence, acetate, phosphate or its aqueous solution, hydrochloric acid, acetic acid, sulphuric acid, phosphoric acid, aminoacid, sodium chloride, potassium chloride, sodium lactate, xylitol, maltose, glucose, fructose, dextran, glycine, starch, sucrose, lactose, mannitol, silicon derivative, cellulose and derivant thereof, alginate, gelatin, polyvinylpyrrolidone, glycerol, Tween 80, agar, calcium carbonate, calcium bicarbonate, Polyethylene Glycol, cyclodextrin, beta-schardinger dextrin-, phospholipid material, Kaolin, Pulvis Talci, calcium stearate, magnesium stearate etc.
In order better to prove, proved beneficial effect of the present invention by following test example.
The antitumor action of test example 1 medicine of the present invention
One, material
(1) medicine
" commercially available PINGXIAO JIA0NANG " is as former engineer testing medication (Xi'an Zhengda Pharmaceutical Co., Ltd. provides); " medicine PINGXIAO JIA0NANG of the present invention " (according to embodiment 1 method preparation) is as test medication (Xi'an Communications University's researches on natural drugs and engineering center provide).With distilled water, be mixed with the suspension solution of desired concn.
(2) tumor strain
S
180sarcoma tumor-bearing mice (experimental animal center, Traditional Chinese Medicine Research Institute, Shanxi Province provides).
(3) animal
ICR strain white mice (Xi'an Communications University's Experimental Animal Center provides, the animal quality quality certification number: No. 08-004th, the moving card of Shan doctor word), male and female dual-purpose, body weight 19-22g, pellet is fed.Room temperature 18-22 ℃, relative humidity 60-70%.
Two, method and result
Under aseptic condition, extract intraperitoneal inoculation S
180the sarcoma cell mouse ascites of 1 week, by 1: 4 times, with physiological saline solution, dilute, then every mice left fore internal organs nest hemostasis 0.2ml under aseptic condition, claims the weight of animals grouping after 24h, starts gastric infusion, every day 1 time, continuous 10 days, after administration in the tenth day, 24h claimed the weight of animals, put to death mice, peel off tumor piece and weigh, pressing column count tumour inhibiting rate.The results are shown in Table 1.
Tumour inhibiting rate (%)=(the average tumor weight of the average tumor weight-matched group of administration group) average tumor weight of * 100%/lotus tumor matched group
The tumor-inhibiting action (X ± SD) of table 1 PINGXIAO JIA0NANG to lotus S180 sarcoma mice
＊P＜0.05
Result shows, each administration group mouse tumor weight average in various degree be less than lotus tumor matched group, compare with negative control group, the heavy dose of group of " commercially available PINGXIAO JIA0NANG " heavy dose of group and test technology all has significant difference; In contrast, each dosage group of medicine of the present invention there are no significant difference.On equal tumour inhibiting rate, the dosage that the dosage of new technology is compared former technique reduces greatly, and new technology human oral consumption is 3-5 tablet/time, and former technique is 4-8 tablet/time.On Isodose, new technology successful is better than the tumour inhibiting rate of former technique.
[Al in test example 2 rat blood serums
3+], [K
+] measure
Test medication is with test example 1
Object: investigate after Oral Administration in Rats commercially available " PINGXIAO JIA0NANG " and medicine of the present invention potassium ion and aluminium ion concentration in serum by test, relatively before and after process reform, in serum, potassium ion, aluminium ion have zero difference, thereby explanation process reform feasibility.If variant, illustrate that process reform affects potassium ion, aluminium ion in serum larger, process reform part is infeasible.
(1) [Al in rat blood serum
3+] measure
1) experiment material
SD rat, fasting 24h before experiment, press respectively 0.63g/kg (commercially available " PINGXIAO JIA0NANG "), 0.45g/kg (medicine of the present invention) gastric infusion, respectively at following time point 0,1,2,4,6h each 2ml that takes a blood sample, proceed to immediately in centrifuge tube at the centrifugal 10min of 3000rpm, draw upper plasma clear liquid to stand-by in clean centrifuge tube.
2) preparation of blank solution
Draw 0.40mL 0.01mol/L hydrochloric acid solution in 2mL volumetric flask, add chromium sky cyanines S solution 0.16mL, hexamethylenetetramine buffer solution 0.40mL, adding distil water is mended to scale, shakes up.
3) drafting of standard curve
Draw respectively the Al of 2.0 μ g/mL
3+standard solution 80,160,240,320,400 μ L, in 2mL volumetric flask, add 0.01mol/L hydrochloric acid solution to 0.40mL, add respectively chromium sky cyanines S solution 0.16mL, hexamethylenetetramine buffer solution 0.40mL, and adding distil water is mended to scale, shakes up.1cm cuvette 550nm wavelength place colorimetric, measures trap.The concentration of aluminum standard solution of take is vertical coordinate, drawing standard curve.
4) sample determination
Accurate absorption in each 100 μ L to 2mL volumetric flasks of plasma sample, adds 0.01mol/L hydrochloric acid solution to 0.3mL.Add chromium sky cyanines S solution 0.16mL, hexamethylenetetramine buffer solution 0.40mL, adding distil water is mended to scale, shakes up.With 1cm cuvette, in 550nm wavelength place colorimetric, measure trap.
5) the results are shown in Figure 1
Commercially available " PINGXIAO JIA0NANG " content, 4h[Al after taking medicine
3+] peaking 1.91x10-4mol/L; 4h[Al after oral " medicine of the present invention " content
3+] peaking 1.99x10-4mol/L.
(2) [K in rat blood serum
+] measure
1) preparation of solution
1. the preparation of potassium standard solution: accurately take the analytical pure potassium chloride 0.1907g through drying, move in 1000mL volumetric flask after water dissolution, thin up standardize solution, to scale, shakes up, and is 100ppm potassium.With this liquid, be diluted to 10,20,30,40,50 and a series of potassium standard solution such as 60ppm.
2. the preparation of blank solution: draw 10% Chile saltpeter 5mL in 25mL volumetric flask, add 5 formaldehyde-EDTA mixed masking agents, 10 glycerol and 1 phenolphthalein indicator, shake up mixing.Drip 1% sodium carbonate and be adjusted to blush, then drip 0.1N hydrochloric acid and be adjusted to colourless.With the syringe with syringe needle, draw the sodium tetraphenylborate precipitation agent 1mL of pH=8, effectively inject fast the 25mL volumetric flask of liquid to be measured, place 5 to 10min, add water and be settled to scale, shake up, as blank solution.
3. 3% sodium tetraphenylborate solution: 19.45mL 0.2mol/L sodium hydrogen phosphate is mixed with 0.55mL 0.1mol/L citric acid, be pH=8 buffer solution.Take 3.0g sodium tetraphenylborate again and be dissolved in buffer solution, be diluted with water to 100mL, be heated to 70 ℃ and keep 1min, filter, placement is spent the night, and stores in brown bottle standby.Cryopreservation in the dark.
4. formaldehyde-EDTA mixed masking agent: take 3g EDETATE DISODIUM and be dissolved in 90mL water, add 37% formaldehyde 10mL, be uniformly mixed, standby.
5. 0.5% phenolphthalein indicator: 0.5g phenolphthalein indicator is dissolved in 100mL 95% ethanol.
6. 1% sodium carbonate liquor: 1g sodium carbonate with standardize solution after water dissolution to 100mL.
7. 0.1N hydrochloric acid solution: get 0.83mL concentrated hydrochloric acid and be diluted to 100mL.
8. 10% sodium nitrate solution: take analytical pure Chile saltpeter 100g in beaker, add after water 300mL dissolves and move in 1000mL volumetric flask, add water and be settled to scale, shake up standby.
2) drafting of standard curve
Draw respectively potassium standard solution 5mL and put into 25mL volumetric flask, then add 5 formaldehyde-EDTA and drip and close screening agent, 10 glycerol and 1 phenolphthalein indicator, shake up mixing.Drip 1% sodium carbonate and be adjusted to blush, with 0.1N hydrochloric acid, be adjusted to colourless.With the syringe with syringe needle, draw the sodium tetraphenylborate precipitation agent 1mL of pH=8, effectively inject fast the volumetric flask of liquid to be measured, make potassium tetraphenylborate be superfine particle.Place 5 to 10min, add water and be settled to scale, shake up, at 440nm wavelength place 1cm cuvette, measure transmittance.Take transmittance as vertical coordinate, and potassium concentration is abscissa drawing standard curve.
3) sample determination
The accurate plasma sample 400 μ L that draw, in 5mL volumetric flask, add 10% Chile saltpeter to 1mL, then add 1 formaldehyde-EDTA mixed masking agent, 2 glycerol and 1 phenolphthalein indicator, shake up mixing.Drip 1% sodium carbonate and be adjusted to blush, then drip 0.1N hydrochloric acid and be adjusted to colourless.With the syringe with syringe needle, draw the sodium tetraphenylborate precipitation agent 1mL of pH=8, effectively inject fast the volumetric flask of liquid to be measured, make potassium tetraphenylborate be superfine particle.Place 5 to 10min, add water and be settled to scale, shake up, measure transmittance.
4) the results are shown in Figure 2
After commercially available " PINGXIAO JIA0NANG " content, 4h[K after taking medicine
+] peaking 4.04x10
-3mol/L; After oral " medicine of the present invention " content, 4h[K after taking medicine
+] peaking 3.78x10
-3mol/L.
(3) conclusion
Experiment discovery, after the content that oral " commercially available PINGXIAO JIA0NANG " and medicine of the present invention make, [K in rat blood serum
+], [Al
3+] there was no significant difference.Before and after process modification, serum [K
+], [Al
3+] without significant change.Prompting thus: process reform part is to serum [K
+], [Al
3+] do not make significant difference, process reform is truly feasible.
Accompanying drawing explanation
Aluminium ion concentration change curve in Fig. 1 rat blood serum
Potassium concentration change curve in Fig. 2 rat blood serum
The specific embodiment
By the specific embodiment below, explaining content of the present invention, is not the further restriction to protection domain of the present invention.
Get weight medical material: Radix Curcumae 54g, Herba Agrimoniae 54g, Oletum Trogopterori 45g, Alumen 54g, Sal Nitri 54g, Resina Toxicodendri 18g processed, stir-baked Fructus Aurantii in bran 90g, Semen Strychni Pulveratum 36g; Above 8 taste medical material Radix Curcumaes, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed are ground into coarse powder, according to percolation under stream preserved material and extractum item, use 70% ethanol percolation, collection percolate, and decompression recycling ethanol obtains extractum A; Get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues and decoct with water 2 times, each 1 hour, decoction liquor was filtered and is merged, and filters, and filtrate concentrate drying obtains powder B; Above-mentioned extractum A, powder B and Semen Strychni Pulveratum mix, and granulate, be dried, encapsulated.
Get weight medical material: Radix Curcumae 30g, Herba Agrimoniae 30g, Oletum Trogopterori 25g, Alumen 30g, Sal Nitri 30g, Resina Toxicodendri 10g processed, stir-baked Fructus Aurantii in bran 50g, Semen Strychni Pulveratum 20g; Above 8 taste medical material Radix Curcumaes, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed are ground into coarse powder, according to percolation under stream preserved material and extractum item, use 60% alcohol reflux, collection extracting solution, and decompression recycling ethanol obtains extractum A; Get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues and decoct with water 1 time, each 3 hours, decoction liquor was filtered and is merged, and filters, and filtrate concentrate drying obtains powder B; Above-mentioned extractum A, powder B and Semen Strychni Pulveratum mix.
embodiment 3
Get weight medical material: Radix Curcumae 10g, Herba Agrimoniae 10g, Oletum Trogopterori 10g, Alumen 10g, Sal Nitri 10g, Resina Toxicodendri 5g processed, stir-baked Fructus Aurantii in bran 30g, Semen Strychni Pulveratum 5g; Above 8 taste medical material Radix Curcumaes, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed are pulverized and are used 80% ethanol ultrasonic extraction, collect extracting solution, and decompression recycling ethanol obtains extractum A; Get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues and decoct with water 3 times, each 2 hours, decoction liquor was filtered and is merged, and filters, and filtrate concentrate drying obtains powder B; Above-mentioned extractum A, powder B and Semen Strychni Pulveratum mix.
Get weight medical material: Radix Curcumae 50g, Herba Agrimoniae 50g, Oletum Trogopterori 50g, Alumen 50g, Sal Nitri 50g, Resina Toxicodendri 60g processed, stir-baked Fructus Aurantii in bran 70g, Semen Strychni Pulveratum 40g; Above 8 taste medical material Radix Curcumaes, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed are ground into coarse powder, according to percolation under stream preserved material and extractum item, use 80% ethanol percolate extraction, collection percolate, and decompression recycling ethanol obtains extractum A; Get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues and decoct with water 1 time, each 3 hours, decoction liquor was filtered and is merged, and filters, and filtrate concentrate drying obtains powder B; Above-mentioned extractum A, powder B and Semen Strychni Pulveratum mix.
embodiment 5
Get weight medical material: Radix Curcumae 40g, Herba Agrimoniae 40g, Oletum Trogopterori 40g, Alumen 40g, Sal Nitri 40g, Resina Toxicodendri 20g processed, stir-baked Fructus Aurantii in bran 60g, Semen Strychni Pulveratum 30g; Above 8 taste medical material Radix Curcumaes, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed are ground into coarse powder, according to percolation under stream preserved material and extractum item, use 70% ethanol percolate extraction, collection percolate, and decompression recycling ethanol obtains extractum A; Get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues and decoct with water 2 times, each 1 hour, decoction liquor was filtered and is merged, and filters, and filtrate concentrate drying obtains powder B; Above-mentioned extractum A, powder B and Semen Strychni Pulveratum mix.
Get any extractum A of embodiment 1-5, powder B and Semen Strychni Pulveratum and mix 100g, add respectively the dextrin of 1.5 times of amounts, 0.5% sucrose, 1.5% microcrystalline Cellulose, makes soft material with appropriate dissolve with ethanol, granulates, and 60 ℃ of forced air dryings, granulate, and granulate, obtains granule.
embodiment 7, drop pill
Get any extractum A of embodiment 1-5, powder B and Semen Strychni Pulveratum and mix 100g, add the Polyethylene Glycol of 1000g, mix homogeneously, melting, upper pill dripping machine, makes drop pill.
Get any extractum A of embodiment 1-5, powder B and Semen Strychni Pulveratum and mix 100g, add 5% polyvinylpolypyrrolidone, 0.1% magnesium stearate, 50% microcrystalline Cellulose, with appropriate alcoholic solution, make soft material, granulate, 60 ℃ of forced air dryings, granulate, granulate, compacting in flakes, obtains oral cavity disintegration tablet.
embodiment 9, injectable powder
Get any extractum A of embodiment 1-5, powder B and Semen Strychni Pulveratum and mix 0.5g, glucose 4.5g, sodium thiosulfate 0.9g and distilled water 1ml, after said components mix homogeneously, lyophilization, 500 of packing, obtain injectable powder.
embodiment 10, tablet
Get any extractum A of embodiment 1-5, powder B and Semen Strychni Pulveratum and mix 100g, with starch, sodium carboxymethyl cellulose, Pulvis Talci mix homogeneously, granulate, and tabletting obtains tablet.
embodiment 11, oral liquid
Get any extractum A of embodiment 1-5, powder B and Semen Strychni Pulveratum and mix 2g, with syrup 4g, be dissolved in the pure water of 100ml, homogenizing, filters, through high-temperature short-time sterilization (135 ℃, 4s).Sterile filling, packing.Make oral liquid.
Group component within the scope of above-described embodiment and description can expand or reduce in scale according to need of production simultaneously.
Claims (10)
1. an antitumor action Chinese medicine composition, is characterized in that, by following step preparation method, is obtained:
(1) get by weight following medicinal materials: Radix Curcumae 1-5 part, Herba Agrimoniae 1-5 part, Oletum Trogopterori 1-5 part, Alumen 1-5 part, Sal Nitri 1-5 part, Resina Toxicodendri 0.5-3 part processed, stir-baked Fructus Aurantii in bran 3-7 part, Semen Strychni Pulveratum 0.5-4 part;
(2) above 8 taste medical materials, get Radix Curcumae, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed and pulverize, ethanol extraction, and the extracting solution extractum A that reduces pressure to obtain, medicinal residues are standby;
(3) get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues and decoct with water, decoction liquor is filtered, and filtrate concentrate drying obtains powder B;
(4) above-mentioned extractum A, powder B and Semen Strychni Pulveratum mix.
2. Chinese medicine composition as claimed in claim 1, it is characterized in that, described in step (1), get weight portion medical material Radix Curcumae 2-4 part, Herba Agrimoniae 2-4 part, Oletum Trogopterori 2-4 part, Alumen 2-4 part, Sal Nitri 2-4 part, Resina Toxicodendri 0.5-2 part processed, stir-baked Fructus Aurantii in bran 4-6 part, Semen Strychni Pulveratum 1-3 part.
3. Chinese medicine composition as claimed in claim 1, is characterized in that, described in step (1), gets 3 parts of weight portion medical material Radix Curcumaes, 3 parts of Herba Agrimoniaes, 2.5 parts of Oletum Trogopteroris, 3 parts of Alumens, 3 parts, Sal Nitri, 1 part of Resina Toxicodendri processed, 5 parts of stir-baked Fructus Aurantii in bran, 2 parts of Semen Strychni Pulveratums.
4. Chinese medicine composition as claimed in claim 1, is characterized in that: the Radix Curcumae described in step (2), stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed are pulverized and used 60-80% ethanol percolation, collect percolate, and decompression recycling ethanol obtains extractum A.
5. Chinese medicine composition as claimed in claim 4, is characterized in that: the Radix Curcumae described in step (2), stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed are pulverized and used 70% ethanol percolation, collect percolate, and decompression recycling ethanol obtains extractum A.
6. Chinese medicine composition as claimed in claim 1, it is characterized in that: get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues described in step (3) decoct with water 1-3 time, each 1-3 hour, decoction liquor is filtered and is merged, filter, filtrate concentrate drying obtains powder B.
7. Chinese medicine composition as claimed in claim 6, it is characterized in that: get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues described in step (3) decoct with water 2 times, each 2 hours, decoction liquor was filtered and is merged, filter, filtrate concentrate drying obtains powder B.
8. the Chinese medicine composition described in claim 1-7 any one is made pharmaceutically acceptable preparation.
9. the preparation method of antitumor action Chinese medicine composition claimed in claim 1, is characterized in that, comprises the steps:
(1) get weight portion medical material Radix Curcumae 1-5 part, Herba Agrimoniae 1-5 part, Oletum Trogopterori 1-5 part, Alumen 1-5 part, Sal Nitri 1-5 part, Resina Toxicodendri 0.5-3 part processed, stir-baked Fructus Aurantii in bran 3-7 part, Semen Strychni Pulveratum 0.5-4 part;
(2) above 8 taste medical materials, get Radix Curcumae, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed and pulverize, ethanol extraction, and the extracting solution extractum A that reduces pressure to obtain, medicinal residues are standby;
(3) get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues and decoct with water, decoction liquor is filtered, and filtrate concentrate drying obtains powder B;
(4) above-mentioned extractum A, powder B and Semen Strychni Pulveratum mix.
10. preparation method as claimed in claim 9, is characterized in that, comprises the steps:
(1) get 3 parts of weight portion medical material Radix Curcumaes, 3 parts of Herba Agrimoniaes, 2.5 parts of Oletum Trogopteroris, 3 parts of Alumens, 3 parts, Sal Nitri, 1 part of Resina Toxicodendri processed, 5 parts of stir-baked Fructus Aurantii in bran, 2 parts of Semen Strychni Pulveratums;
(2) above 8 taste medical material Radix Curcumaes, stir-baked Fructus Aurantii in bran, Resina Toxicodendri processed are pulverized and are used 70% ethanol percolation, collect percolate, and decompression recycling ethanol obtains extractum A;
(3) get Herba Agrimoniae, Alumen, Sal Nitri, Oletum Trogopterori and above-mentioned medicinal residues and decoct with water 2 times, each 2 hours, decoction liquor was filtered and is merged, and filters, and filtrate concentrate drying obtains powder B;
(4) above-mentioned extractum A, powder B and Semen Strychni Pulveratum mix.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210265111.6A CN103566282B (en) | 2012-07-27 | 2012-07-27 | A kind of Traditional Chinese medicine composition with anti-tumor effect and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210265111.6A CN103566282B (en) | 2012-07-27 | 2012-07-27 | A kind of Traditional Chinese medicine composition with anti-tumor effect and preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103566282A true CN103566282A (en) | 2014-02-12 |
| CN103566282B CN103566282B (en) | 2017-05-31 |
Family
ID=50039563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210265111.6A Active CN103566282B (en) | 2012-07-27 | 2012-07-27 | A kind of Traditional Chinese medicine composition with anti-tumor effect and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103566282B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104055975A (en) * | 2014-07-01 | 2014-09-24 | 崔丽萍 | Anti-tumor traditional Chinese medicine preparation |
| CN104958476A (en) * | 2015-07-03 | 2015-10-07 | 刘明璇 | External medicament for treating tumor and preparation method thereof |
| CN106389872A (en) * | 2016-09-26 | 2017-02-15 | 魏庆 | Traditional Chinese medicine composition for preventing and treating tumors and preparation method of traditional Chinese medicine composition for preventing and treating tumors |
| CN114642714A (en) * | 2020-12-18 | 2022-06-21 | 西安正大制药有限公司 | Anti-tumor traditional Chinese medicine composition extract, preparation method and application thereof in inhibiting breast cancer lung metastasis |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1362139A (en) * | 2001-01-05 | 2002-08-07 | 杨孟君 | Nano Pingxiao medicine and its preparation |
| CN1390560A (en) * | 2001-06-07 | 2003-01-15 | 吴戈 | Orally applied anticancer tablet |
| CN1569197A (en) * | 2004-04-30 | 2005-01-26 | 甘肃独一味生物制药有限责任公司 | Chinese medicinal soft capsule and preparing process thereof |
| CN101284120A (en) * | 2008-05-29 | 2008-10-15 | 宁夏金太阳药业有限公司 | Process for preparing Pingxiao preparation |
-
2012
- 2012-07-27 CN CN201210265111.6A patent/CN103566282B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1362139A (en) * | 2001-01-05 | 2002-08-07 | 杨孟君 | Nano Pingxiao medicine and its preparation |
| CN1390560A (en) * | 2001-06-07 | 2003-01-15 | 吴戈 | Orally applied anticancer tablet |
| CN1569197A (en) * | 2004-04-30 | 2005-01-26 | 甘肃独一味生物制药有限责任公司 | Chinese medicinal soft capsule and preparing process thereof |
| CN101284120A (en) * | 2008-05-29 | 2008-10-15 | 宁夏金太阳药业有限公司 | Process for preparing Pingxiao preparation |
| CN101574506A (en) * | 2008-05-29 | 2009-11-11 | 宁夏金太阳药业有限公司 | Method for preparing pingxiao preparation |
Non-Patent Citations (1)
| Title |
|---|
| 国家药典委员会编: "《中华人民共和国药典：2010年版 一部》", 31 January 2010, 中国医药科技出版社 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104055975A (en) * | 2014-07-01 | 2014-09-24 | 崔丽萍 | Anti-tumor traditional Chinese medicine preparation |
| CN104055975B (en) * | 2014-07-01 | 2018-11-02 | 福州市长乐区长胜信息技术有限公司 | A kind of antitumor Chinese medicine preparation |
| CN104958476A (en) * | 2015-07-03 | 2015-10-07 | 刘明璇 | External medicament for treating tumor and preparation method thereof |
| CN106389872A (en) * | 2016-09-26 | 2017-02-15 | 魏庆 | Traditional Chinese medicine composition for preventing and treating tumors and preparation method of traditional Chinese medicine composition for preventing and treating tumors |
| CN114642714A (en) * | 2020-12-18 | 2022-06-21 | 西安正大制药有限公司 | Anti-tumor traditional Chinese medicine composition extract, preparation method and application thereof in inhibiting breast cancer lung metastasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103566282B (en) | 2017-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112972547A (en) | Traditional Chinese medicine composition for treating qi-blood deficiency syndrome and preparation method and application thereof | |
| CN104644697B (en) | The preparation method and applications of ganoderma lucidum Ultramicro-powder | |
| CN101904893B (en) | Angelica sinensis blood enriching capsule and preparation method thereof | |
| CN1931217B (en) | Medicine composition of gingko leaf and rhodiola root | |
| CN105362340B (en) | A kind of pharmaceutical composition for treating leukaemia and preparation method thereof | |
| CN101057925B (en) | Preparation technology for 'jieguqili' capsule | |
| CN1299742C (en) | Medicine for treating diabetes, and its prepn. method | |
| CN103566282B (en) | A kind of Traditional Chinese medicine composition with anti-tumor effect and preparation method | |
| CN103271978B (en) | Ginkgo leaf compound preparation for resisting oxygen deprivation and glucose deprivation and treating altitude sickness | |
| CN1887324B (en) | Chinese medicine composition for treating liver and kidney defect, and its preparation process and analysis method | |
| CN102068509A (en) | Method for preparing pulsatilla chinensis (Bunge) Regel active ingredient, method for preparing preparation of pulsatilla chinensis (Bunge) Regel active ingredient and application of pulsatilla chinensis (Bunge) Regel active ingredient in preparation of antineoplastic medicament | |
| CN103566281B (en) | A kind of Traditional Chinese medicine composition with anti-tumor effect and preparation method | |
| CN101020016B (en) | Medicine for treating fracture and injured tendon and its preparation | |
| CN1813984B (en) | Chinese medicine preparation for treating liver disease and preparing method | |
| CN107308317B (en) | Traditional Chinese medicine composition for preventing and treating radiation damage | |
| CN101011543B (en) | Antineoplastic medicine composition | |
| CN100482266C (en) | Medical composite prepared by sarcandra and oldenlandia | |
| CN104688723B (en) | Application of icaritin in preparation of medicine for treating anemia | |
| CN102526387B (en) | Medicinal composition for treating early-stage diabetic foot and preparation method thereof | |
| CN103156891B (en) | Preparation method of akebia fruit active components and preparation method of preparation of akebia fruit active components and application in preparation of antineoplastic medicines of preparation of foreknowledge sub-active components | |
| CN104546952A (en) | Active component of selaginella doederleinii hieron as well as preparation method and use thereof | |
| CN1899410A (en) | Medicine for treating cardiovascular disease and its preparing method and quality control method | |
| CN101700323B (en) | Pharmaceutical composition for preventing and treating liver cancer | |
| CN112915066B (en) | Glabrous sarcandra herb formula granules and preparation method thereof | |
| CN102846831B (en) | Chinese medicine composition as well as preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |